Traditional and Complementary Medicine Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 5) (2012; 17 pages)
Abstract
For thousands of years, traditional medicine (TM) has
been an important source of health care for much of the
world, and many populations use and value TM not only
as the source of their primary health care but also as part
of their spiritual and cultural belief systems. Meanwhile,
people in Europe, Australia, and North America have
increasingly embraced TM, also referred to as complementary
and alternative medicine (CAM), by using herbal
medications to complement their standard health care.
Attractive features of TM practices include greater accessibility
in many parts of the world, cultural acceptance in
low- and middle-income countries, comparatively low
cost and, often, a lesser need for modern technology. In
developed countries, CAM is used for preventing disease
and maintaining wellness, in addition to complementing
conventional care for chronic and acute health conditions.
Although TM/CAM has a great influence on health care
practices, there is wide variation from country to country
in policies, laws, and regulations governing the safety,
quality, and efficacy of TM/CAM therapies. Many consumers
use herbal products to treat themselves—often
without a health practitioner’s knowledge or advice.
Consumers and practitioners may not be adequately
informed about potential adverse effects, drug interactions,
and how to use herbal medicines safely. Lack
of regulations on quality standards and evaluation for
safety and efficacy of these products may cause problems,
resulting in the marketing of unsafe or ineffective TM/
CAM products.
Countries that already have a strong pharmaceutical
regulatory structure in place should adapt their existing
systems to include herbal medications, and countries that
lack regulatory standards should work toward setting up
a national system that encompasses both pharmaceuticals
and herbal medicines. All countries should have
some framework in place to review and monitor herbal
medicines, including a regulatory agency, a national
advisory committee, and a system to monitor adverse
reactions from herbal medicines.
Expanding the credibility and integration of TM/CAM
will require developing an evidence base for safety and
efficacy, which means consolidating data from existing
national and international studies and supporting new
research to fill evidence gaps.
|